SCHEMBL6295986

SCHEMBL6295986

O=C(O)c1c(-c2ccccc2Cl)[nH]c2ccc(F)cc2c1=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.51
ALDH1A1 P00352 2/20 0.51
GLA P06280 1/20 0.51
GAA P10253 1/20 0.51
HTT P42858 1/20 0.51
CCNB2 O95067 1/20 0.43
CDK1 P06493 1/20 0.43
CCNB1 P14635 1/20 0.43
GSK3B P49841 1/20 0.43
CDK5 Q00535 1/20 0.43
CDK5R1 Q15078 1/20 0.43
CCNB3 Q8WWL7 1/20 0.43
TUBB4A P04350 1/20 0.42
TUBB P07437 1/20 0.42
TUBA3C P0DPH7 1/20 0.42
TUBA1B P68363 1/20 0.42
TUBA4A P68366 1/20 0.42
TUBB4B P68371 1/20 0.42
TUBB3 Q13509 1/20 0.42
TUBB2A Q13885 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6295963 0.88 MAP2 (0.47) KDM4EALDH1A1CCNB2CDK1CCNB1
SCHEMBL6294653 0.88 KDM4E (0.54) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6295699 0.84 KDM4E (0.59) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6300573 0.83 ALOX5 (0.58) KDM4EALDH1A1GAALMNAHPGD
SCHEMBL6295691 0.83 TUBB4A (0.55) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6300802 0.82 ABCG2 (0.54) KDM4EALDH1A1GAACCNB2CDK1
SCHEMBL6295994 0.81 MAP2 (0.45) KDM4EALDH1A1CCNB2CDK1CCNB1
SCHEMBL6294977 0.81 ALDH1A1 (0.48) KDM4EALDH1A1GLAGAAHTT
SCHEMBL25199917 0.81 KDM4E (0.42) KDM4EALDH1A1GLAGAAHTT
SCHEMBL6294973 0.80 ALDH1A1 (0.52) KDM4EALDH1A1GLAGAAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897316-B2 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-05-24 US disclosed
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents CHINA MEDICAL UNIVERSITY (TW) 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032832-A1 Substituted 2-phenyl-4-quinolone-3-carboxylic acid compounds and their use as antitumor agents TP53, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CHUK KDM4E 1042/4885ALDH1A1 465/4885GLA 1754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.